EverQuote (NASDAQ: EVER) reported Q2 EPS of ($0.07), $0.03 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $105.1 million versus the consensus estimate of $102.29 million.

GUIDANCE:

EverQuote sees Q3 2021 revenue of $109-111 million, versus the consensus of $111.6 million.

• Variable Marketing Margin of $33 - $34 million, a year-over-year increase of 14% at the mid-point.
• Adjusted EBITDA in the range of $4.5 - $5.5 million, a year-over-year decrease of 4% at the mid-point.

EverQuote sees FY2021 revenue of $440-446 million, versus the consensus of $439.9 million.

• Variable Marketing Margin of $138 - $141 million, a year-over-year increase of 28% at the mid-point and an increase from our previous guidance of $136 - $140 million.
• Adjusted EBITDA in the range of $23 - $26 million, a year-over-year increase of 33% at the mid-point and a decrease from our previous guidance of $26 - $30 million. Full year 2021 Adjusted EBITDA is expected to be impacted by incremental investments in preparation for this year’s health open enrollment period which takes place in the fourth quarter.

For earnings history and earnings-related data on EverQuote (EVER) click here.